MedTrace Logo

Evaluation of Etafilcon A Daily Disposable Lenses

NCT02061592 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 136

Last updated 2018-06-19

Study results available
· View outcomes & findings →

Summary

To evaluate the clinical performance of daily disposable etafilcon A lenses.

Conditions

  • Myopia

Interventions

DEVICE

etafilcon A

DEVICE

etafilcon A

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2014-03-31
Completion
2014-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02061592 on ClinicalTrials.gov